location:Home > 2021 Vol.2 Sept.No3 > Application of pueraria root and its extract in the treatment of cardiovascular and cerebrovascular diseases

2021 Vol.2 Sept.No3

  • Title: Application of pueraria root and its extract in the treatment of cardiovascular and cerebrovascular diseases
  • Name: Konami Yoshida,Bin Shimada
  • Company: (Beppu University,Biefu 125-0062,Japan)
  • Abstract:

    Objective: To explore the effective application of pueraria root and its extract in the treatment of cardiovascular and cerebrovascular diseases, and to summarize the efficacy of pueraria root and its extract in the treatment of cardiovascular and cerebrovascular diseases through the study of clinical cases, so as to provide reference for clinical medication safety. Methods: According to the inclusion and exclusion principle, 123 patients with cardiovascular and cerebrovascular diseases diagnosed in our hospital from January 2018 to October 2018 were selected and randomly divided into two groups using the number table method. Patients in the western medicine group were treated with conventional western medicine according to their types of cardiovascular and cerebrovascular diseases. The patients in the traditional Chinese medicine group were treated with pueraria root and its extract, and then the effective rate of drug treatment was compared between the two groups. Results: According to the data comparison, the clinical treatment effective rate of patients in the western medicine group was 76.81%, and the clinical treatment effective rate of patients in the Chinese medicine group was 92.34%. Conclusion: Through the clinical intervention of 123 patients with cardiovascular and cerebrovascular diseases, it is concluded that pueraria root and its extract have good pharmacological value and clinical efficacy in the treatment of cardiovascular and cerebrovascular diseases, can effectively improve the clinical symptoms of patients, and can be used as the first choice for clinical treatment of cardiovascular and cerebrovascular diseases.


  • Keyword: Radix puerariae; Cardiovascular and cerebrovascular; Extracts; Inclusion and exclusion principles
  • DOI: 10.12250/jpcarme2021020356
  • Citation form: Konami Yoshida,Bin Shimada.Application of pueraria root and its extract in the treatment of cardiovascular and cerebrovascular diseases.2020, vol. 3, 30-36.
Reference:

[1] Yafang,Zhang,Linfeng,He,Cheng,Ma,Cheng,Wang,Honglin,Zhou,Chaocheng,Guo,Lihong,Gong,Yan,Wan,Cheng,Peng,Yunxia,Li.Research progress on the pharmacy of tetramethylpyrazine and its pharmacological activity in cardiovascular and cerebrovascular diseases.[J].The Journal of pharmacy and pharmacology,2022,74(6):843-860.

[2] Sebastián Acosta,Daniel J. Penny,Ken M. Brady,Craig G. Rusin.An effective model of cerebrovascular pressure reactivity and blood flow autoregulation[J].Microvascular Research: An International Journal,2018,115:34-43.

[3] Francesco,Moroni,Enrico,Ammirati,Atticus H,Hainsworth,Paolo G,Camici.Association of White Matter Hyperintensities and Cardiovascular Disease: The Importance of Microcirculatory Disease.[J].Circulation. Cardiovascular imaging,2020,13(8):e010460.

[4] Blair, Gordon W.,Appleton, Jason P.,Law, Zhe Kang,Doubal, Fergus,Flaherty, Katie,Dooley, Richard,Shuler, Kirsten,Richardson, Carla,Hamilton, Iona,Shi, Yulu,Stringer, Michael,Boyd, Julia,Thrippleton, Michael J.,Sprigg, Nikola,Bath, Philip M.,Wardlaw, Joanna M..Preventing cognitive decline and dementia from cerebral small vessel disease: The LACI-1 Trial. Protocol and statistical analysis plan of a phase IIa dose escalation trial testing tolerability, safety and effect on intermediary endpoints of isosorbide mononitrate and cilostazol, separately and in combination[J].International journal of stroke: official journal of the International Stroke Society,2018,13(5):530-538.

[5] Tiantian Ji,Yingxin Zhao,Juan Wang,Yi Cui,Dandan Duan,Qiang Chai,Hua Zhang,Zhendong Liu.Effect of Low-Dose Statins and Apolipoprotein E Genotype on Cerebral Small Vessel Disease in Older Hypertensive Patients: A Subgroup Analysis of a Randomized Clinical Trial[J].Journal of the American Medical Directors Association,2018,19(11):995-1002.

[6] Wolff,V.,Armspach,J.-P.,Beaujeux,R.,Manisor,M.,Rouyer,O.,Lauer,V.,Meyer,N.,Marescaux,C.,Geny,B..High frequency of intracranial arterial stenosis and cannabis use in ischaemic stroke in the young[J].Cerebrovascular diseases,2014,37(6):438-443.

[7] Shasha,Chen,Christopher,Lotz,Norbert,Roewer,Jens-Albert,Broscheit.Comparison of volatile anesthetic-induced preconditioning in cardiac and cerebral system: molecular mechanisms and clinical aspects.[J].European journal of medical research,2018,23(1):10.


Tsuruta Institute of Medical Information Technology
Address:[502,5-47-6], Tsuyama, Tsukuba, Saitama, Japan TEL:008148-28809 fax:008148-28808 Japan,Email:jpciams@hotmail.com,2019-09-16